{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:12:54Z","timestamp":1779923574125,"version":"3.53.1"},"reference-count":40,"publisher":"The Korean Association for the Study of the Liver","issue":"2","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"name":"National Institute of Infectious Disease","award":["2020-E5105-02"],"award-info":[{"award-number":["2020-E5105-02"]}]},{"name":"National Institute of Infectious Disease","award":["2020-E5104-02"],"award-info":[{"award-number":["2020-E5104-02"]}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:p>Background\/Aims: We used next-generation sequencing (NGS) to analyze resistance-associated substitutions (RASs) and retreatment outcomes in patients with chronic hepatitis C virus (HCV) infection who failed direct-acting antiviral agent (DAA) treatment in South Korea.Methods: Using prospectively collected data from the Korean HCV cohort study, we recruited 36 patients who failed DAA treatment in 10 centers between 2007 and 2020; 29 blood samples were available from 24 patients. RASs were analyzed using NGS.Results: RASs were analyzed for 13 patients with genotype 1b, 10 with genotype 2, and one with genotype 3a. The unsuccessful DAA regimens were daclatasvir+asunaprevir (n=11), sofosbuvir+ribavirin (n=9), ledipasvir\/sofosbuvir (n=3), and glecaprevir\/pibrentasvir (n=1). In the patients with genotype 1b, NS3, NS5A, and NS5B RASs were detected in eight, seven, and seven of 10 patients at baseline and in four, six, and two of six patients after DAA failure, respectively. Among the 10 patients with genotype 2, the only baseline RAS was NS3 Y56F, which was detected in one patient. NS5A F28C was detected after DAA failure in a patient with genotype 2 infection who was erroneously treated with daclatasvir+asunaprevir. After retreatment, 16 patients had a 100% sustained virological response rate.Conclusions: NS3 and NS5A RASs were commonly present at baseline, and there was an increasing trend of NS5A RASs after failed DAA treatment in genotype 1b. However, RASs were rarely present in patients with genotype 2 who were treated with sofosbuvir+ribavirin. Despite baseline or treatment-emergent RASs, retreatment with pan-genotypic DAA was highly successful in Korea, so we encourage active retreatment after unsuccessful DAA treatment.<\/jats:p>","DOI":"10.3350\/cmh.2022.0345","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T08:20:42Z","timestamp":1678177242000},"page":"496-509","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Next-generation sequencing analysis of hepatitis C virus resistance\u2013associated substitutions in direct-acting antiviral failure in South Korea"],"prefix":"10.3350","volume":"29","author":[{"given":"Kyung-Ah","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Bum","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3954-5908","authenticated-orcid":true,"given":"Seungtaek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-7990","authenticated-orcid":true,"given":"Sook Hyang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1902","reference":[{"key":"ref1","volume-title":"","year":"2021"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0230"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20882"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3851\/imp3025"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.11.011"},{"key":"ref6","first-page":"976","volume-title":"Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals","author":"Dietz","year":"2018"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09975-y"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19272"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2017017"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25412"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25575"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19260"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.024"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.020"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"ref16","first-page":"2078","volume-title":"1000 Genome Project Data Processing Subgroup. The Sequence Alignment\/Map format and SAMtools","author":"Li","year":"2009"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv098"},{"key":"ref18","first-page":"80","volume-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","author":"Cingolani","year":"2012"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-475"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14507"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2016.22.1.76"},{"key":"ref22","first-page":"40","volume-title":"Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018. Drug Resist Updat 2018;37:17-39","author":"Sorbo","year":"2018"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0826-1"},{"key":"ref24","first-page":"100462","volume-title":"Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals","author":"Howe","year":"2022"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.004"},{"key":"ref26","first-page":"2987","volume-title":"Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide","author":"Wu","year":"2019"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198642"},{"key":"ref28","first-page":"452","volume-title":"EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol 2020;73:1170-1218","year":"2023"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13474"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3851\/imp3149"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1208953"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0247-z"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu697"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14849"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.592472"},{"key":"ref36","first-page":"1503","volume-title":"Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol 2013;85:1724-1733","author":"Seong","year":"2017"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31060"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01249-18"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.576572"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01381-3"}],"updated-by":[{"DOI":"10.3350\/cmh.2022.0345e","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000}}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2022-0345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2022.0345","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2022-0345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T07:31:59Z","timestamp":1681457519000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2022.0345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2022.0345","relation":{"correction":[{"id-type":"doi","id":"10.3350\/cmh.2022.0345e","asserted-by":"object"}]},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"value":"2287-2728","type":"print"},{"value":"2287-285X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"2022-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}